valproic acid has been researched along with Factor XIII Deficiency in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Factor XIII Deficiency: A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor (FSF) that prevents blood clot formation and results in a clinical hemorrhagic diathesis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teich, M | 1 |
| Longin, E | 1 |
| Dempfle, CE | 1 |
| König, S | 1 |
1 other study available for valproic acid and Factor XIII Deficiency
| Article | Year |
|---|---|
Factor XIII deficiency associated with valproate treatment.
Topics: Anticonvulsants; Child; Epilepsies, Myoclonic; Epilepsy, Absence; Epilepsy, Generalized; Epistaxis; | 2004 |